Crewe Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.3K Sell
974
-12
-1% -$1.05K 0.01% 356
2026
Q1
$84K Sell
986
-90
-8% -$8.02K 0.01% 320
2025
Q4
$85K Hold
1,076
0.01% 305
2025
Q3
$86K Sell
1,076
-129
-11% -$11K 0.01% 313
2025
Q2
$110K Sell
1,205
-1
-0.1% -$91 0.02% 208
2025
Q1
$113K Sell
1,206
-55
-4% -$4.92K 0.02% 186
2024
Q4
$115K Sell
1,261
-994
-44% -$94.9K 0.02% 193
2024
Q3
$234K Buy
2,255
+7
+0.3% +$713 0.03% 138
2024
Q2
$218K Buy
2,248
+985
+78% +$90.9K 0.02% 170
2024
Q1
$114K Buy
+1,263
New +$107K 0.01% 256
2023
Q4
Sell
-561
Closed -$39.9K 463
2023
Q3
$39.9K Sell
561
-6
-1% -$449 0.01% 157
2023
Q2
$43.7K Buy
567
+17
+3% +$1.32K 0.01% 281
2023
Q1
$41.3K Sell
550
-79
-13% -$5.87K 0.01% 332
2022
Q4
$49.6K Sell
629
-158
-20% -$11.8K 0.01% 305
2022
Q3
$55K Buy
787
+153
+24% +$12K 0.01% 305
2022
Q2
$51K Buy
634
+134
+27% +$10.5K 0.01% 293
2022
Q1
$38K Hold
500
0.01% 245
2021
Q4
$43K Buy
+500
New +$39K 0.01% 200
2020
Q4
Sell
-49
Closed -$4K 484
2020
Q3
$4K Buy
+49
New +$3.74K ﹤0.01% 387

Other funds holding CL

Crewe Advisors's CL Position: Q2 2026 in Review

Crewe Advisors reduced its Colgate-Palmolive (CL) stake by 1.2% in Q2 2026, selling an estimated $1.05K and leaving 974 shares worth $89.3K. The position accounts for 0.01% of the portfolio, ranked #356.

Crewe Advisors first reported a position in CL in Q3 2020 and has held it in 19 quarters since. The position peaked at $234K in Q3 2024. 668 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Crewe Advisors held 974 shares of Colgate-Palmolive worth $89.3K as of Q2 2026.
  • Crewe Advisors sold 12 Colgate-Palmolive shares in Q2 2026, an estimated $1.05K.
  • Colgate-Palmolive made up 0.01% of Crewe Advisors's portfolio in Q2 2026, its #356 holding.
  • Crewe Advisors first reported a position in Colgate-Palmolive in Q3 2020 and has held it in 19 quarters since.
  • Crewe Advisors's Colgate-Palmolive position peaked at $234K in Q3 2024.
  • 668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.